NCT04764604View on ClinicalTrials.gov

Evaluating the Feasibility of Acapella® Choice as a Dysphonia Treatment

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

December 14, 2020

Primary Completion Date

November 29, 2021

Study Completion Date

November 29, 2021

Conditions
Muscle Tension DysphoniaVocal Fold PalsyVocal Cord ParalysisPresbylarynxDysphonia
Interventions
DEVICE

Acapella Choice

3 minutes of exercise consisting of blowing through the device (on setting '5') and phonating at the same time.

DEVICE

Tube-in-water

3 minutes of exercise consisting of blowing through a silicone tube (10mm internal diameter) submerged in 5 cm of water whilst phonating at the same time.

Trial Locations (1)

NW1 2PG

Royal National ENT Hospital, UCLH Hospitals NHS Trust, London

All Listed Sponsors
collaborator

Smiths Medical, ASD, Inc.

INDUSTRY

lead

University College, London

OTHER

NCT04764604 - Evaluating the Feasibility of Acapella® Choice as a Dysphonia Treatment | Biotech Hunter | Biotech Hunter